ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Funding Opportunities
Food and Drug AdministrationHHS-FDA

Research on Complex Generics

Funder: United States Food and Drug Administration

Posted Nov 13, 2026·Last checked Nov 22, 2026·open

AGENCY

Food and Drug Administration

PROGRAM

Discretionary

AMOUNT

$0 – $2.5M

CLOSES

Dec 14, 2026

Description

The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.

Eligibility

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Contact

Stephanie Bogan Grantor

patrick.johnson@fda.hhs.gov

3018276802

Additional details

Department
HHS-FDA
Funding instrument
Cooperative Agreement
Cost sharing required
No
Archived
Jan 13, 2027

Opportunity number: RFA-FD-27-001

Quote this number when you contact the agency or apply.